Stephanie S Leonard, CRNA - Medicare Certified Registered Nurse Anesthetist (crna) in Toledo, OH

Stephanie S Leonard, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Toledo, Ohio. She graduated from nursing school in 2019 and has 5 years of diverse experience with area of expertise as Certified Registered Nurse Anesthetist (crna). She is a member of the group practice Promedica Central Physicians and her current practice location is 2142 N Cove Blvd, Toledo, Ohio. You can reach out to her office (for appointments etc.) via phone at (419) 291-4491.

Stephanie S Leonard is licensed to practice in Ohio (license number APRN.CRNA.019981) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1063052033.

Contact Information

Stephanie S Leonard, CRNA
2142 N Cove Blvd,
Toledo, OH 43606-3895
(419) 291-4491
(419) 479-6905



Provider's Profile

Full NameStephanie S Leonard
GenderFemale
SpecialityCertified Registered Nurse Anesthetist (crna)
Experience5 Years
Location2142 N Cove Blvd, Toledo, Ohio
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Stephanie S Leonard graduated from nursing school in 2019
  NPI Data:
  • NPI Number: 1063052033
  • Provider Enumeration Date: 01/08/2020
  • Last Update Date: 10/08/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 9537594247
  • Enrollment ID: I20200127000126

Medical Identifiers

Medical identifiers for Stephanie S Leonard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063052033NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367500000XNurse Anesthetist, Certified Registered APRN.CRNA.019981 (Ohio)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Promedica Central Physicians2365348190818

News Archive

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Ameritox applauds President Trump's declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stephanie S Leonard allows following entities to bill medicare on her behalf.
Entity NameSouthwest Ohio Anesthesia Consultants Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588645188
PECOS PAC ID: 6901700640
Enrollment ID: O20031124000399

News Archive

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Ameritox applauds President Trump's declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).

Read more Medical News

› Verified 9 days ago

Entity NamePromedica Central Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043270150
PECOS PAC ID: 2365348190
Enrollment ID: O20031211000226

News Archive

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Ameritox applauds President Trump's declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).

Read more Medical News

› Verified 9 days ago

Entity NameNorthstar Anesthesia Of Ohio Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417276429
PECOS PAC ID: 3173648300
Enrollment ID: O20100927000005

News Archive

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Ameritox applauds President Trump's declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stephanie S Leonard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stephanie S Leonard, CRNA
333 N Summit St Fl 7,
Toledo, OH 43604-1531

Ph: (419) 291-4491
Stephanie S Leonard, CRNA
2142 N Cove Blvd,
Toledo, OH 43606-3895

Ph: (419) 291-4491

News Archive

Doubt cast on LABA withdrawal in combination asthma therapy

Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled corticosteroid, after finding the approach often results in destabilization of their condition.

Ameritox applauds President Trump's declaration of opioid crisis as national public health emergency

Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.

Benefits of long-term Kineret therapy in people with NOMID

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

ACADIA initiates new pimavanserin Phase III trial for Parkinson's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).

Read more News

› Verified 9 days ago


Nurse Anesthetist, Certified Registered Nurses in Toledo, OH

Mr. John Scribner, C.R.N.A.
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 4452 Cullen Ln, Toledo, OH 43611
Phone: 419-215-6511    
Lyndsay Brentlinger, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 2142 N Cove Blvd, Toledo, OH 43606
Phone: 419-531-8808    Fax: 419-531-9342
Gregory Halstead, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 2213 Cherry St, Toledo, OH 43608
Phone: 419-251-4524    Fax: 419-245-6018
Ms. Jamie L Nash, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 2142 N Cove Blvd, Toledo, OH 43606
Phone: 419-471-4491    Fax: 419-479-6905
Christine Sophia Harwood, CRNA
Nurse Anesthetist - CR
Medicare: May Accept Medicare Assignments
Practice Location: 2213 Cherry St, Toledo, OH 43608
Phone: 419-251-3232    
Kellyn A Diller, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 2142 N Cove Blvd, Toledo, OH 43606
Phone: 419-291-4491    Fax: 419-479-6905
Stacey Rissman, CRNA
Nurse Anesthetist - CR
Medicare: Medicare Enrolled
Practice Location: 2213 Cherry St, Toledo, OH 43608
Phone: 419-251-3232    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.